PMGC Holdings (ELAB) Capital Leases (2026)
PMGC Holdings' (ELAB) quarterly Capital Leases came in at $274248.0 in Q2 2026, little changed quarter-over-quarter from $274248.0 in Q1 2026.
Powered by 
Analysis
PMGC Holdings (ELAB) Capital Leases (2026) Analysis & Trends
PMGC Holdings has disclosed Capital Leases across 1 years of filings, most recently posting $274248.0 for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.37 Bn | 192.39 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.14 Bn | 176.96 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.30 Bn | 123.45 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.71 Bn | 73.72 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.30 Bn | 55.12 Bn | 1.37 Bn |
| 6 | Moderna | 53.94 Bn | 48.80 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.23 Bn | 29.92 Bn | 992.69 Mn |
| 8 | Biogen | 31.82 Bn | 30.54 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.04 Bn | 29.04 Bn | 1.16 Mn |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 |